
₹14,820(15 Shares)
Minimum Investment
IPO Dates
Aug 24, 2026 – Aug 27, 2026
Price Band
₹938–988 per equity share
Issue Size
₹1757 Cr
Lot Size
15
Listing
Sep 1, 2026
Listing At
BSE, NSE
NII Sub-Categories
bHNI (> ₹10L)
Bids above ₹10L
sHNI (< ₹10L)
Bids ₹2L to ₹10L
Overall Subscription
Total Bids Received
75.06x
NII
26.63L
QIB
35.51L
Anchor
53.26L
Individual
62.14L
Employee
33.41K
bhni
17.75L
shni
8.88L
employees
33.41K
shareholder
1.78Cr
Incorporated in 2002, Symbiotec Pharmalab Ltd. is a biopharmaceutical and bio technological company whose operations include development and manufacture of active pharmaceutical ingredients, nutrition...
EPS (Pre-IPO)
17.82
EPS (Post-IPO)
17.39
P/E (Pre-IPO)
55.44
P/E (Post-IPO)
56.81
RoNW
9.48%
PAT Margin
12.60%
P/B Value
5.35
Market Cap
₹6,244.43 Cr.
* All figures are in ₹ Crores unless otherwise stated.
385/2, Pigdamber, Rau, Mhow, Indore, Madhya Pradesh, 453331
MUFG Intime India Pvt.Ltd.
JM Financial Ltd.
Motilal Oswal Investment Advisors Ltd.
Avendus Capital Pvt.Ltd.
Nomura Financial Advisory & Securities (India) Pvt.Ltd.
The Symbiotec Pharmalab IPO price band is set at ₹938.00 to ₹988.00 per equity share.
The total issue size of Symbiotec Pharmalab IPO is ₹1757 Cr.
The lot size for Symbiotec Pharmalab IPO is 15 shares per lot. The minimum investment amount is approximately ₹14,820.
The Symbiotec Pharmalab IPO opens on Aug 24, 2026 and closes on Aug 27, 2026.
The basis of allotment for Symbiotec Pharmalab IPO is expected to be finalized on Aug 28, 2026.
Symbiotec Pharmalab IPO is expected to be listed on Sep 1, 2026 on BSE, NSE.
The current GMP for Symbiotec Pharmalab IPO is ₹185, suggesting an expected listing price of around ₹1123.00. Note: GMP is an unofficial market indicator.
The registrar for Symbiotec Pharmalab IPO is MUFG Intime India Pvt.Ltd.. You can contact them at symbiotecpharmalab.ipo@in.mpms.mufg.com.

Sahajanand Medical Technologies
Price Band: ₹327–₹344

Zetwerk Manufacturing Business
Price Band: ₹143–₹151